Cite
HARVARD Citation
Wen, Y. et al. (2022). Efficacy and safety of phosphatidylinositol 3-kinase inhibitors in patients with chronic lymphocytic leukemia: a meta-analysis and systematic review. Expert review of hematology. 15 (9), pp. 849-856. [Online].